AnaptysBio, Inc. (ANAB)
43.69
+0.49
(+1.13%)
USD |
NASDAQ |
Jan 06, 15:46
AnaptysBio Research and Development Expense (Annual): 163.23M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 74.43M |
| Ovid Therapeutics, Inc. | 36.37M |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| CorMedix, Inc. | 3.942M |
| Verastem, Inc. | 81.33M |